The Connectivity Map: a new tool for biomedical research
The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
Abstract
The ultimate objective of biomedical research is to connect human diseases with the genes that underlie them and drugs that treat them. But this remains a daunting task, and even the most inspired researchers still have to resort to laborious screens of genetic or chemical libraries. What if at least some parts of this screening process could be systematized and centralized? And hits found and hypotheses generated with something resembling an internet search engine? These are the questions the Connectivity Map project set out to answer.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, they do not support complex molecular readouts such as transcriptome profiling, which is one of the most comprehensive and informative measures of cellular response 5 .”
From Pooled CRISPR screening with single-cell transcriptome readout. (2017) · cites this paper as [5]
In the citing paper
“This tool allowed researchers to investigate genome-wide effects of GHK and establish that GHK-Cu is able to up- and down-regulate a significant number of human genes.”
From Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data (2018) · cites this paper as [3]
Citations
Cites
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
Gene Expression Omnibus: NCBI gene expression and hybridization array data repository
Edgar, R. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.1.207 · Cited by 13,288
Golub, T. R., Slonim, D. K., Tamayo, P., Huard, C., Gaasenbeek, M., Mesirov, J. P., Coller, H., Loh, M. L., Downing, J. R., Caligiuri, M. A., et al. (1999) · Science · doi:10.1126/science.286.5439.531 · Cited by 11,516
Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells
Elbashir, S. M., Harborth, J., Lendeckel, W., Yalcin, A., Weber, K., & Tuschl, T. (2001) · Nature · doi:10.1038/35078107 · Cited by 9,456
Goodman and Gilman's the Pharmacological Basis of Therapeutics
Stigelman, W. H., & Pharm, D. (1986) · Military Medicine · doi:10.1093/milmed/151.1.386 · Cited by 6,782
Lamb, J., Crawford, E. D., Peck, D., Modell, J. W., Blat, I. C., Wrobel, M. J., Lerner, J., Brunet, J.-P., Subramanian, A., Ross, K. N., et al. (2006) · Science · doi:10.1126/science.1132939 · Cited by 5,257
Self-citationDruker, B. J., Talpaz, M., Resta, D. J., Peng, B., Buchdunger, E., Ford, J. M., Lydon, N. B., Kantarjian, H., Capdeville, R., Ohno-Jones, S., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200104053441401 · Cited by 5,243 · cited 1×
“) to rationality (chronic myeloid leukaemia–BCR-ABL–imatini”
Lehmann, J. M., Moore, L. B., Smith-Oliver, T. A., Wilkison, W. O., Willson, T. M., & Kliewer, S. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.22.12953 · Cited by 3,625
ONCOMINE: A Cancer Microarray Database and Integrated Data-Mining Platform
Rhodes, D. R., Yu, J., Shanker, K., Deshpande, N., Varambally, R., Ghosh, D., Barrette, T., Pander, A., & Chinnaiyan, A. M. (2004) · Neoplasia · doi:10.1016/s1476-5586(04)80047-2 · Cited by 3,612
A gene atlas of the mouse and human protein-encoding transcriptomes
Su, A. I., Wiltshire, T., Batalov, S., Lapp, H., Ching, K. A., Block, D., Zhang, J., Soden, R., Hayakawa, M., Kreiman, G., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400782101 · Cited by 3,475
Cited by
Items 701–800 of 984
Inferring Infection Patterns Based on a Connectivity Map of Host Transcriptional Responses
Han, L., He, H., Li, F., Cui, X., Xie, D., Liu, Y., Zheng, X., Bai, H., Wang, S., & Bo, X. (2015) · Scientific Reports · doi:10.1038/srep15820 · Cited by 3
“We represented pathogen-to-pathogen HTR relationships as association scores computed with a GSEA-based PRL comparing method 10, 11, 14 .”
MethodPoissy, J., Terrier, O., Lina, B., Textoris, J., & Rosa‐Calatrava, M. (2016) · Réanimation · doi:10.1007/s13546-016-1188-1 · Cited by 3
“Cette analyse repose notamment sur l’exploitation de la base de données Connectivity Map [60] (Broad Institute, MIT) qui recense plus de 7 000 profils transcriptomiques obtenus après traitement de cellules par 1 309 molécules différentes, la plupart possédant une auto-”
BackgroundInfluentialSoysal, E., Lee, H.-J., Zhang, Y., Huang, L.-C., Chen, X., Wei, Q., Zheng, W. J., Chang, J. T., Cohen, T., Sun, J., et al. (2017) · CPT Pharmacometrics & Systems Pharmacology · doi:10.1002/psp4.12174 · Cited by 3
Lu, S., Fan, X.-N., Chen, L., & Lu, X. (2018) · PLoS ONE · doi:10.1371/journal.pone.0203871 · Cited by 3
“There exist other data sets that used small molecules or drugs to perturb cell signaling systems and obtained the expression profile changes of cells, such as CMap data [43, 44] and LINCS data [45, 46].”
SIGN: similarity identification in gene expression
Tonekaboni, S. A. M., Manem, V. S., El-Hachem, N., & Haibe‐Kains, B. (2019) · Bioinformatics · doi:10.1093/bioinformatics/btz485 · Cited by 3
Lemus, E. H. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819668-7.00007-5 · Cited by 3
Even, S., Bouchard, D. S., & Loir, Y. L. (2014) · HAL · Cited by 5
Rouillard, A. D., Wang, Z., & Ma’ayan, A. (2015) · Computational Biology and Chemistry · doi:10.1016/j.compbiolchem.2015.06.003 · Cited by 3
“The goal of the Connectivity Map is to help researchers find connections between drugs, genes, and diseases by matching patterns across gene expression signatures of DE genes [18].”
BackgroundRetractedSYSTEMS ANALYSIS OF COMPLEX BIOLOGICAL DATA FOR BIOPROCESS ENHANCEMENT
Charaniya, S. (2008) · University of Minnesota Digital Conservancy (University of Minnesota) · Cited by 4
Masson, S. W. C., Madsen, S., Cooke, K. C., Potter, M., Díaz‐Vegas, A., Carroll, L., Thillainadesan, S., Cutler, H. B., Walder, K. R., Cooney, G. J., et al. (2023) · eLife · doi:10.7554/elife.86961.2 · Cited by 3
Identifying the HIV-Resistance-Related Factors and Regulatory Network via Multi-Omics Analyses
Long, X., Liu, G., Liu, X., Zhang, C., Shi, L., & Zhu, Z. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252111757 · Cited by 4
“By using CMap [48] to analyze the 12 shared HIV-resistance-related DEGs, we found 12 small molecules as potential therapeutic drugs for AIDS (Table S39).”
MethodKRT14 is a promising prognostic biomarker of breast cancer related to immune infiltration
Liao, S., Zhang, X., Chen, L., Zhang, J., Lu, W., Rao, M., Zhang, Y., Ye, Z., Ivanova, D., Li, F., et al. (2025) · Molecular Immunology · doi:10.1016/j.molimm.2025.02.016 · Cited by 4
Sasaki, E., Hamaguchi, I., Hasegawa, H., & Takahashi, Y. (2025) · Vaccine · doi:10.1016/j.vaccine.2025.127267 · Cited by 2
Fu, Y.-H., Ng, K. M., Tseng, C.-Y., Huang, A.-C., Tu, C.-H., Chen, W.-C., Lang, P.-C., Hsiung-Fei, C., & Lin, L. (2026) · Cell Death Discovery · doi:10.1038/s41420-026-02957-8 · Cited by 2
“While these studies established an association between metabolic reprogramming and drug resistance, the precise consequences of TKI resistance on metabolic alterations remain unclear.”
Siddique, M. A. B., Debnath, A., & Nath, N. D. (2025) · Microbial Bioactives · doi:10.25163/microbbioacts.8110414 · Cited by 2
Tufael, & Siddique, M. A. B. (2025) · Microbial Bioactives · doi:10.25163/microbbioacts.8110370 · Cited by 2
Pathway Interactions Based on Drug-Induced Datasets
Kim, S. (2019) · Cancer Informatics · doi:10.1177/1176935119851518 · Cited by 2
Strub, M. D., Ramachandran, S. S., Boudko, D. Y., Meleshkevitch, E. A., Pezzulo, A. A., Subramanian, A., Liberzon, A., Bridges, R. J., & McCray, P. B. (2021) · CPT Pharmacometrics & Systems Pharmacology · doi:10.1002/psp4.12751 · Cited by 2
“6 We previously used a transcriptomics-based drug discovery approach by using CMAP (build 02) to identify drugs that mimicked the miR-138 overexpression and SIN3A knockdown treatments.”
MethodXu, H., Hu, Y., Peng, X., & Chen, E. (2023) · Immunopharmacology and Immunotoxicology · doi:10.1080/08923973.2023.2261146 · Cited by 2
“Then, the cMAP database (https://clue.io/) [28–30] was then employed to predict small molecules capable of improving the prognosis of LUAD individuals on ground of these genes.”
MethodA gene-based score for the risk stratification of stage IA lung adenocarcinoma
Xiong, Y., Ma, Y., Liu, K., Lei, J., Zhao, J., Zhu, J., Wang, W., Wen, M., Wang, X., Sun, Y., et al. (2024) · Respiratory Research · doi:10.1186/s12931-023-02647-4 · Cited by 2
“…related genes are highly correlated with diseases and their possible molecular mechanisms of action by comparing gene expression profile data to establish the association between genes, diseases and drugs [27, 28]) to find chemotherapeutic drugs that may be effective for high-risk IA populations.”
BackgroundMethodChoi, E. Y., Song, J., Lee, Y., Jeong, Y., & Jang, W. (2024) · Human Genomics · doi:10.1186/s40246-024-00591-y · Cited by 2
“CLUE generates drug-gene connections by analyzing gene expression and proteomics assays including the LINCS L1000 and CMAP databases [37, 38].”
MethodZatorski, N., Sun, Y., Elmas, A., Dallago, C., Karl, T., Stein, D., Rost, B., Huang, K.-L., Walsh, M., & Schlessinger, A. (2024) · iScience · doi:10.1016/j.isci.2024.110640 · Cited by 2
“Furthermore, we applied SAGES drug perturbation signatures from the Connectivity map 24 to investigate the similarity between existing breast cancer drugs and the breast cancer SAGES signature.”
Potential prognostic and immunologic significances of ADAM8 in clear cell renal cell carcinoma
Chu, M. C., Zhang, Z. L., Wang, Z.-Q., Li, Z. Y., & Guo, Y. S. (2025) · Medicine · doi:10.1097/md.0000000000041375 · Cited by 2
Zou, S., Zhang, S., Long, Q., Cao, Y., & Zhang, W. (2013) · Genetic Testing and Molecular Biomarkers · doi:10.1089/gtmb.2012.0449 · Cited by 2
“Screening of related small molecules The Connectivity Map (CMap) is a collection of transcriptional expression data and pattern-matching algorithms that together enable the discovery of function associations between drugs, genes, and diseases (Lamb et al., 2006; Lamb, 2007; Wen et al., 2011).”
BackgroundResetting Skin Genome Back to Health Naturally with GHK
Pickart, L., Vasquez-Soltero, J. M., & Margolina, A. (2016) · Springer eBooks · doi:10.1007/978-3-662-47398-6_162 · Cited by 2
Nakazato, T., Bono, H. U., & Takagi, T. (2011) · InTech eBooks · doi:10.5772/18805 · Cited by 2
“A genetic disorder is a disease caused by abnormalities in genes and chromosomes, and researchers often report the identification of disease-relevant genes and correlations between phenotypes and genotypes (Butte & Kohane 2006; Lamb 2007; PerezIratxeta et al. 2002, 2005, 2007).”
Desai, K., Brott, D., Hu, X. T., & Christianson, A. M. K. (2011) · IEEE International Conference on Bioinformatics and Biomedicine (BIBM) · doi:10.1109/bibm.2011.86 · Cited by 2
“A review of literature pertaining to hematopoietic regulation reveals the key role of a set of proteins involved in neutrophil production and maturity [17-19].”
BackgroundTseng, A. H., Chung, F.-H., Lee, H.-C., Wu, L.-C., Chen, C.-H., & Su, L. (2012) · Genomic Medicine Biomarkers and Health Sciences · doi:10.1016/j.gmbhs.2012.04.001 · Cited by 2
“The imported query was compared with predefined signatures of therapeutic compounds and ranked according to the connectivity score (þ1 to e1).(7)”
MethodAltered oncomodules underlie chromatin regulatory factors driver mutations
Frigola, J., Iturbide, A., López-Bigas, N., Peiró, S., & González-Pérez, A. (2016) · Oncotarget · doi:10.18632/oncotarget.8752 · Cited by 2
“Finally, we ranked these oncomodules according to prior knowledge on tumorigenesis and information from several high throughput cancer genomics and perturbaomics datasets [10, 11].”
MethodApplication of Connectivity Map Database to Research on Chinese Materia Medica
Lv, C., Wang, Y., Liu, R., & Zhang, W. (2016) · Chinese Herbal Medicines · doi:10.1016/s1674-6384(16)60019-9 · Cited by 2
Data Analytics for Pharmaceutical Discoveries
Fakhraei, S., Onukwugha, E., & Getoor, L. C. (2015) · Cited by 4
The Effect of the Human Plasma Molecule GHK-Cu on Stem Cell Actions and Expression of Relevant Genes
Pickart, L., & Margolina, A. (2018) · OBM Geriatrics · doi:10.21926/obm.geriatr.1803009 · Cited by 3
“The Connectivity Map is a database that contains more than 7,000 gene expression profiles of 5 human cell lines treated with 1,309 distinct small molecules [30].”
BackgroundQiao, Z., & Kondo, T. (2019) · Journal of Electrophoresis · doi:10.2198/jelectroph.63.9 · Cited by 2
“Pediatr Blood Cancer2013 Jul;60(7):1095–102.”
A Computational Platform and Guide for Acceleration of Novel Medicines and Personalized Medicine
Melas, I. N., Sakellaropoulos, T., Hur, J., Messinis, D. E., Guo, E. Y., Alexopoulos, L. G., & Bai, J. P. F. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9089-4_10 · Cited by 2
Identification of key genes and pathways associated with Crohn's disease by bioinformatics analysis
Wang, Z., Zhu, J., Liu, C., & Ma, L. (2019) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365521.2019.1665096 · Cited by 2
“Connectivity Map (CMap) represents a useful bioinformatic technique for establishing the connections among genes, drugs and diseases [13,14].”
MethodStahnke, T., Gajda-Deryło, B., Stachs, O., Guthoff, R. F., Jünemann, A., & Füllen, G. (2019) · Klinische Monatsblätter für Augenheilkunde · doi:10.1055/a-1037-9990 · Cited by 2
“Basierend auf den Genexpressionsdaten wurde in der Folge ein In-silico-Wirkstoff-Screening in der Connectivity-Map-Datenbank [17] durchgeführt.”
BackgroundNew approaches to antibacterial drug discovery
Turan, N. B. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-818480-6.00008-4 · Cited by 3
Understanding Tamoxifen Resistance of Breast Cancer Based on Integrative Bioinformatics Approaches
Dai, Y., & Huang, L. J. (2012) · Springer eBooks · doi:10.1007/978-1-4614-5647-6_14 · Cited by 2
Meta-Path-Based Probabilistic Soft Logic for Drug–Target Interaction Predictions
Zhang, S., & Sun, Y. (2025) · Mathematics · doi:10.3390/math13243958 · Cited by 2
Gene Expression Microarrays in Cancer Research
Yan, J., & Gu, W. (2009) · Springer eBooks · doi:10.1007/978-1-4419-0131-6_20 · Cited by 3
“Gene expression signatures have been used to create the Connectivity Map for finding ‘‘connections’’ among small-molecule drugs, genes, and diseases [ 75 ].”
MethodChallenges and solutions in drug-target interaction prediction
Ezzat, A. (2018) · DR-NTU (Nanyang Technological University) · doi:10.32657/10356/75771 · Cited by 4
“Drug and Target Data Types of data that are available for drugs and may be used for training DTI classifiers include – but are not limited to – graphical representations of drugs’ chemical structures [56], side effects [57], ATC (Anatomical Therapeutic Chemical) codes [58] and gene expression responses to drugs [59].”
BackgroundKita, K., Thakkar, P. V., Galletti, G., Madhukar, N. S., Vila-Navarro, E., Barasoaín, I., Goodson, H. V., Sackett, D. L., Díaz, J. F., Elemento, O., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/838334 · Cited by 2
Drug Repurposing and Multi-Target Therapies
Kumar, A. P., Lukman, S., & Nguyen, M. N. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-809633-8.20160-x · Cited by 3
Deng, J., Lai, G., Zhang, C., Li, K., Zhu, W., Xie, B., & Zhong, X. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e25570 · Cited by 2
“…map (CMap) database (https://clue.io/) containing drug genome data could explore potential therapeutic compounds targeting disease genes according to the expression characteristics, and also reveal the mechanisms of action (MOA) of compounds targeting corresponding molecular pathways [41].”
BackgroundPredictive toxicology of phytochemicals
Enoch, S. J., Nahar, L., & Sarker, S. D. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-16102-5.00012-2 · Cited by 1
Li, G., Lam, C. Y., Chen, R., Wang, X., Zhang, H., Fu, F., & Zhou, H. (2025) · Scientific Reports · doi:10.1038/s41598-025-25535-x · Cited by 1
“The Connectivity Map (CMap) database (http://www.broadinstitute.org) was used to identify potential compounds associated with the risk groups defined by the PTex model 46 .”
Николаевна, Н. И., & Rizzarelli, E. (2025) · Antioxidants · doi:10.3390/antiox14121512 · Cited by 3
“…of GHK/GHK-Cu was initially restricted to aged-skin remodeling [209] and regeneration [205] until Pickart et al. highlighted that GHK can activate numerous genes involved in nervous system physiology, development, and maintenance [214], using the Broad Institute’s Connectivity Map (cMap) [215].”
Integrative cell subtype-to-drug discovery technology for angiomyolipomas treatment
Cao, J., Chang, X., Deng, S., Yang, H., Guo, G., & Chen, P. (2025) · Biomedical Technology · doi:10.1016/j.bmt.2025.100117 · Cited by 1
Zhang, J., Lin, K., Jiang, C., Zheng, J., Huang, H., & Han, J. (2026) · Pharmaceuticals · doi:10.3390/ph19040540 · Cited by 1
“Among them, CMap is a non-labeled method that works by linking input transcriptional “signatures” to gene expression profiles induced by thousands of small molecules with known mech-https anisms of action [14].”
Biomarker Discovery Strategies: DNA, RNA, and Protein
Vilar, E., & Tabernero, J. M. (2012) · Springer eBooks · doi:10.1007/978-1-4419-9755-5_17 · Cited by 1
Systems Medicine: A New Model for Health Care
MacArthur, L. H., Mhyre, T. R., Connors, E. E., Vasudevan, S., Crooke, E., & Federoff, H. J. (2012) · Springer eBooks · doi:10.1007/978-1-4614-4998-0_51 · Cited by 1
Profiling Bortezomib Resistance in Multiple Myeloma: Implications in Personalized Pharmacotherapy
Mitra, A., Stessman, H. A. F., Shaughnessy, J. D., & Ness, B. V. (2014) · Resistance to targeted anti-cancer therapeutics · doi:10.1007/978-3-319-06752-0_5 · Cited by 1
Ceci, M., Guzzi, P. H., Masciari, E., Coluccia, M., Mandreoli, F., Mecella, M., Fumarola, F., Martoglia, R., & Penzo, W. (2012) · ACM SIGHIT Record · doi:10.1145/2384556.2384558 · Cited by 1
Shi, H. J., Zhang, D., Hao, Y., & Xiao, Z. (2015) · Science China Earth Sciences · doi:10.1007/s11430-014-5035-9 · Cited by 1
Using gene sets to identify putative drugs for breast cancer
Hsiao, T., Chen, H.-I. H., Chen, Y., Chen, Y., & Chuang, E. Y.-Y. (2012) · IEEE International Conference on Bioinformatics and Biomedicine (BIBM) · doi:10.1109/bibm.2012.6392616 · Cited by 1
“RESULT “Gene sets – drugs” assocaited netwrok A total of 2,588 expression profiles treated by 1,118 kinds of drugs were downloaded from Cmap [12].”
BackgroundMethodZhu, L., Liang, F., Liu, J., Rayner, S., Li, Y., Chen, S., & Xiong, J. (2011) · IEEE International Conference on Systems Biology · doi:10.1109/isb.2011.6033168 · Cited by 1
“For example, the Connectivity Map (CMAP) [1, 2] project set out to create a reference collection of geneexpression profiles from cultured human cells treated with bioactive small molecules.”
BackgroundComputational Approaches to Analyze the Strategies of Drug Repositioning*
Da-Fei, X. I. E., Li, P., Li, F., Bo, X., & Wang, S. (2012) · PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS · doi:10.3724/sp.j.1206.2011.00558 · Cited by 1
Knowledge-Driven, Data-Assisted Integrative Pathway Analytics
Reddy, P. S., Murray, S., & Liu, W. (2013) · IGI Global eBooks · doi:10.4018/978-1-4666-3604-0.ch009 · Cited by 1
Chemoinformatic Approaches to Target Identification
Gregori‐Puigjané, E., & Keiser, M. J. (2012) · Royal Society of Chemistry eBooks · doi:10.1039/9781849734912-00050 · Cited by 2
Translation of Biomarkers into Clinical Utility
Trepicchio, W. L., & Mulligan, G. (2008) · Methods in pharmacology and toxicology · doi:10.1007/978-1-59745-439-1_12 · Cited by 1
REACH and Environmental Chemicals
Taboureau, O., Audouze, K., & Brunak, S. (2015) · QSAR in environmental and health sciences · doi:10.1201/b19189-5 · Cited by 1
(2014) · CRC Press eBooks · doi:10.1201/b16439-5 · Cited by 2
Computational approaches to drug target identification
Freeman, T. B., & Lum, P. Y. (2016) · Cambridge University Press eBooks · doi:10.1017/cbo9780511989421.003 · Cited by 1
Commission de Recherche Translationnelle de la Société de Réanimation de Langue Française, Guillon, A., Gibot, S., Ait‐Oufella, H., Uhel, F., Monneret, G., Sharshar, T., Taccone, F. S., Textoris, J., Tamion, F., et al. (2017) · Médecine Intensive Réanimation · doi:10.1007/s13546-017-1279-7 · Cited by 1
“Cette analyse repose notamment sur l'exploitation de la base de données Connectivity Map [36] , qui recense les profils transcriptomiques cellulaires obtenus après traitement par 1309 molécules différentes, la plupart possédant une autorisation de mise sur le marché.”
BackgroundDiscovery Technologies for Drug Repurposing
Issa, N. T., Byers, S. W., & Dakshanamurthy, S. (2017) · Methods and principles in medicinal chemistry · doi:10.1002/9783527674381.ch4 · Cited by 3
Network Pharmacology Study of the Shexiang Baoxin Pill
Zhao, J., Jiang, P., Liu, R., & Zhang, W. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-812744-5.00012-6 · Cited by 1
Gene module analysis of juvenile myelomonocytic leukemia and screening of anticancer drugs
Zhao, W., Wang, L., & Yu, Y. (2018) · Oncology Reports · doi:10.3892/or.2018.6709 · Cited by 1
“The CMap database (23,24) stores the genome-wide expression profiles of human cells treated with various active small molecules.”
BackgroundCardio-oncology: Network-Based Prediction of Cancer Therapy-Induced Cardiotoxicity
Cheng, F. (2019) · Challenges and advances in computational chemistry and physics · doi:10.1007/978-3-030-16443-0_5 · Cited by 1
Ling, J., Chang, A., Ye, H., Zhao, H., & Zhuo, X. (2021) · Inhalation Toxicology · doi:10.1080/08958378.2021.1908461 · Cited by 1
“…of potential drugs that reverse FA-induced malignant transformation To predict the small agents that attenuate FA-induced cell transformation, the connectivity mapping (CMAP) database that contains whole genomic expression profiles for small active molecular inferences (Lamb 2007) was used.”
MethodTenenbaum, J. D., Shah, N. H., & Altman, R. B. (2021) · Springer eBooks · doi:10.1007/978-3-030-58721-5_26 · Cited by 2
Ye, F. (2017) · Methods and principles in medicinal chemistry · doi:10.1002/9783527674381.ch11 · Cited by 1
Wang, Y., Qi, J., & Ai, D. (2022) · Briefings in Bioinformatics · doi:10.1093/bib/bbac517 · Cited by 3
Sarmah, D. T., Paul, A., Kumar, S., Bairagi, N., & Chatterjee, S. (2023) · Physica A Statistical Mechanics and its Applications · doi:10.1016/j.physa.2023.128955 · Cited by 1
Evaluation of immune microenvironment in IgG4-related sialadenitis
Hu, Q., Zhou, P., Yan, Y., & Huang, Q. (2023) · Cellular and Molecular Biology · doi:10.14715/cmb/2023.69.15.37 · Cited by 1
“CMAP connected drugs, genes and diseases through a collection of gene expression signa - tures obtained from cultured human cells treated with bioactive small molecules (12, 13).”
BackgroundIn-Silico Identification of Novel Pharmacological Synergisms: The Trabectedin Case
Mannarino, L., Ravasio, N., D’Incalci, M., Marchini, S., & Masseroli, M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25042059 · Cited by 1
“Dataset clustering was performed with the dendrogram and linkage functions from the sciPy library version 1.5.0 [36], using the Ward variance minimization algorithm.”
BackgroundMethodInfluentialColorectal cancer subtyping and immune landscape analysis based on natural killer cell-related genes
Ding, M., Gao, J., Wang, J., Li, Z., Gong, X., Cui, Z., Li, C., Xue, H., Li, D., & Wang, Y. (2024) · Arab Journal of Gastroenterology · doi:10.1016/j.ajg.2024.03.005 · Cited by 1
Lu, H., Zhao, W., Zhang, B., Xie, Y., He, J., Yang, H., & Wang, Z. (2024) · Analytical Cellular Pathology · doi:10.1155/2024/2868534 · Cited by 1
Oskotsky, T., Tang, X., Arthurs, E., Govil, A., Abbasi, F., Bhoja, A., Bunis, D. G., Lau, A., Einhaus, J. F., Diop, M., et al. (2026) · iScience · doi:10.1016/j.isci.2026.117153 · Cited by 5
“…leveraged a transcriptomics-based computational drug repositioning pipeline 17 using gene expression signatures of endometriosis queried against the Connectivity Map (CMap) database, 41 and identified fenoprofen as the top drug among 299 unique therapeutic candidates 23 (Figure 1A and Table S1).”
Computational approaches for the systematic analysis of aging-associated molecular alterations
Debès, C., Leote, A. C., & Beyer, A. (2018) · Drug Discovery Today Disease Models · doi:10.1016/j.ddmod.2019.03.003 · Cited by 1
Гриб, І., Мироненко, В. В., & Motronenko, V. (2021) · Біомедична інженерія і технологія · doi:10.20535/2617-8974.2021.5.231333 · Cited by 1
Finding Hsp90 inhibitors by drug repurposing: The power of chemical genetics
Xiong, M., & Zhang, H. (2012) · Drug Discovery Today · doi:10.1016/j.drudis.2012.03.009 · Cited by 1
Boosting L-type Ca 2+ channel activity in tuberous sclerosis mitigates excess glutamate receptorsPreprint
Niere, F., Cacheaux, L. P., Egido‐Betancourt, H. X., Taylor, W. C., & Raab‐Graham, K. F. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.08.26.269209 · Cited by 2
Jiang, P., Cao, Y., Gao, F., Sun, W., Liu, J., Ma, Z., Xie, M., & Fu, S. (2020) · Research Square · doi:10.21203/rs.3.rs-50778/v3 · Cited by 1
Liesenborghs, I. (2022) · Research Publications (Maastricht University) · doi:10.26481/dis.20221201il · Cited by 1
Párraga-Leo, A., Sebastián-León, P., Sánchez-Reyes, J. M., Sanz, F., Vidal, C., Sanchez-Ribas, I., Remohi, J. A., Pellicer, A., Sirota, M., & Díaz-Gimeno, P. (2025) · medRxiv · doi:10.1101/2025.11.04.25339037 · Cited by 2
Magkoufopoulou, C. (2011) · Research Publications (Maastricht University) · doi:10.26481/dis.20111208cc
The Application of Omics Technologies to the Study of Mammalian Toxicology
Auerbach, S. S., & Merrick, B. A. (2015) · Wiley eBooks · doi:10.1002/9781118683484.ch3
Computational and Bioinformatic Strategies for Drug Repositioning
Mazzarella, R. A., & Webb, C. P. (2012) · Wiley eBooks · doi:10.1002/9781118274408.ch5 · Cited by 1
Introduction: Genomics and Personalized Medicine
Semizarov, D., & Blomme, E. A. G. (2008) · Wiley eBooks · doi:10.1002/9780470409770.ch1
Use of genetic technologies to compare medicines
Kolitz, S. E., Towfic, F., Grossman, I., Hayden, M. R., & Zeskind, B. J. (2014) · Clinical Genetics · doi:10.1111/cge.12462
“CMAP contains 7000+ gene expression profiles representing the impact of over 1300+ compounds in a standardized set of cell lines (24, 25).”
BackgroundChemical genomics and combo therapy
Stegmaier, K. (2010) · Blood · doi:10.1182/blood-2010-10-312108
“Now revealed after Pin1-induced conformational rearrangement, SH3 domains of p47phox can associate with the membrane-bound p22phox and complete the assembly and activation of the NADPH oxidase (5).”
BackgroundIdentifying susceptibility networks for drug-induced non-immune neutropenia
Desai, K., Brott, D., Hu, X. T., & Christianson, A. M. K. (2014) · International Journal of Data Mining and Bioinformatics · doi:10.1504/ijdmb.2015.066339
Ma, C., Harry, H.-I., Huang, Y., & Chen, Y. (2011) · IEEE International Conference on Bioinformatics and Biomedicine Workshops (BIBMW) · doi:10.1109/bibmw.2011.6112555
“This work takes the advantage of the Connectivity Map (cMap) [12] project data but aims at addressing the problems existed in the original cMap algorithm.”
BackgroundReconsidering phenotypic heart failure drug discovery
Toomey, J. R., & Upson, J. J. (2012) · Drug Discovery Today Therapeutic Strategies · doi:10.1016/j.ddstr.2014.01.003
SEARCHING FOR RADIOSENSITIZERS: DEVELOPMENT OF A NOVEL ASSAY AND HIGH-THROUGHPUT SCREENING
Katz, D. R. (2008) · TSpace (University of Toronto)
van Berlo, R. J. P. (2010) · Research Repository (Delft University of Technology)
Gene ontology fuzzy-enrichment analysis to investigate drug mode-of-action
Iorio, F., Murino, L., di Bernardo, D., Raiconi, G., & Tagliaferri, R. (2010) · International Joint Conference on Neural Networks (IJCNN) · doi:10.1109/ijcnn.2010.5596585
“The used data were retrieved from a public available database: the Connectivity Map (cMap) [5] [6].”
MethodMolecular Genetic Insights in Cytogenetically-Normal Pediatric Acute Myeloid Leukemia
Hollink, I. H. I. M. (2011) · EUR Research Repository (Erasmus University Rotterdam)
A computational framework for predicting drug Mode-of-Action
Ma, C., Chen, H.-I. H., Huang, Y., & Chen, Y. (2010) · IEEE International Conference on Bioinformatics and Biomedicine Workshops (BIBMW) · doi:10.1109/bibmw.2010.5703831
“One important work is the Connectivity Map Project[1,2], which generates a particular database including over 1,000 drug treatment on five different cell lines with several concentrations.”
Background
Metadata
- Authors
- Lamb, J.
- Affiliations
- Broad Institute (US)
- Corresponding author
- Lamb, Justin
- Venue
- Nature Reviews Cancer
- Published
- 2007-01
- Volume
- 7
- Issue
- 1
- Pages
- 54-60
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2029980980
- Semantic Scholar
- d1610ee5045d33be16a9a72a514fea537ba46306
- Cited by
- 945
- References
- 66
- Citations by year
- 2026: 11 · 2025: 29 · 2024: 75 · 2023: 54 · 2022: 56 · 2021: 100 · 2020: 79 · 2019: 64 · 2018: 60 · 2017: 52 · 2016: 58 · 2015: 57 · 2014: 42 · 2013: 49 · 2012: 56
- FWCI
- 1.22
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Broad Institute
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bioinformatics and Genomic Networks
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gene expression and cancer classification
- Keywords
- Connectivity Map, gene-disease association, drug repurposing, gene expression profiling, cancer research, drug discovery
- MeSH terms
- Algorithms, Animals, Gene Expression Regulation, Humans, Information Services, Models, Biological, Models, Genetic, Neoplasms, Phenotype, Software, Information Storage and Retrieval, Genome, Computational Biology, Biomedical Research
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.